Narumi Harada-Shoji

5PUBLICATIONS
13CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 20, 2026
Liquid Chromatography-Tandem Mass Spectrometry Quantification of Diet-Derived CYP2D6 Biomarkers for Clinical Phenotyping in Japanese Subjects.

|Oct 06, 2025
Emergence of PALB2 Reversion Mutations as a Mechanism of Resistance to Niraparib in Breast Cancer: A Case Report.

Maako Kawamura, Hiroshi Tada, Hidekazu Shirota

|Sep 09, 2025
A Novel Approach for Cisplatin-Resistant Esophageal Squamous Cell Carcinoma via Amino Acid Transporter LAT1 Inhibition.

Takeru Mozumi, Narumi Harada-Shoji, Yohei Ozawa

|Feb 09, 2024
Mitochondrial dynamics as a novel treatment strategy for triple-negative breast cancer.

Yuechen Wang, Narumi Harada-Shoji, Narufumi Kitamura

|Sep 10, 2021
Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer.

Haruhiko Shindo, Narumi Harada-Shoji, Akiko Ebata

Pageof 1

Frequent Collaborators

3 joint publications

Minoru Miyashita

2 joint publications

Akiko Ebata

2 joint publications

Takashi Suzuki

1 joint publications

Tomoyoshi Soga